These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8332363)

  • 1. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
    Fehér J; Prónai L
    Orv Hetil; 1993 Jun; 134(26):1417-9. PubMed ID: 8332363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation.
    Masini A; Efrati C; Merli M; Attili AF; Amodio P; Ceccanti M; Riggio O
    Am J Gastroenterol; 1999 Nov; 94(11):3323-7. PubMed ID: 10566738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
    Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
    Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lactulose].
    Prat F; Lambert R
    Gastroenterol Clin Biol; 1990; 14(6-7):567-75. PubMed ID: 2397865
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lactitol in chronic idiopathic constipation in children].
    Pitzalis G; Deganello F; Mariani P; Chiarini-Testa MB; Virgilii F; Gasparri R; Calvani L; Bonamico M
    Pediatr Med Chir; 1995; 17(3):223-6. PubMed ID: 7567643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [1st use of lactitol in the treatment of porto-systemic encephalopathy].
    Bircher J; Bührer M; Franz K; van Velthuijsen JA
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1306-7. PubMed ID: 7134954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
    Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
    Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactulose--a multifaceted substance.
    Huchzermeyer H; Schumann C
    Z Gastroenterol; 1997 Oct; 35(10):945-55. PubMed ID: 9370144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients].
    Grandi M; Sacchetti C; Pederzoli S; Celani MF
    Minerva Gastroenterol Dietol; 1991; 37(4):225-30. PubMed ID: 1805974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
    Lanthier PL; Morgan MY
    Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen excretion after ingestion of five different sugar alcohols and lactulose.
    Würsch P; Koellreutter B; Schweizer TF
    Eur J Clin Nutr; 1989 Dec; 43(12):819-25. PubMed ID: 2697552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First and second generation non absorbable disaccharides in the treatment of hepatic encephalopathy.
    Capocaccia L; Riggio O; Merli M
    Ital J Gastroenterol; 1990 Dec; 22(6):365-7. PubMed ID: 2131958
    [No Abstract]   [Full Text] [Related]  

  • 13. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
    Morgan MY
    Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
    Bongaerts G; Severijnen R; Timmerman H
    Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study.
    Pai CH; Huang YS; Jeng WC; Chan CY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):31-6. PubMed ID: 7712392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lactulose in the treatment of hepatic (pre)coma].
    Grijm R
    Ned Tijdschr Geneeskd; 1978 Feb; 122(6):198-200. PubMed ID: 24187
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
    Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786
    [No Abstract]   [Full Text] [Related]  

  • 18. Disaccharides in the treatment of hepatic encephalopathy.
    Sharma P; Sharma BC
    Metab Brain Dis; 2013 Jun; 28(2):313-20. PubMed ID: 23456517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonabsorbable disaccharides for hepatic encephalopathy.
    Als-Nielsen B; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2004; (2):CD003044. PubMed ID: 15106187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.
    Cammà C; Fiorello F; Tinè F; Marchesini G; Fabbri A; Pagliaro L
    Dig Dis Sci; 1993 May; 38(5):916-22. PubMed ID: 8482191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.